Literature DB >> 29366395

Validity and reliability of self-reported health indicators among women attending organized mammographic screening.

Kaitlyn M Tsuruda1, Silje Sagstad1, Sofie Sebuødegård1, Solveig Hofvind1,2.   

Abstract

AIMS: Risk factors for breast cancer are often used for adjustment in epidemiological studies, including in the evaluation of early performance measures in mammographic screening. Information about risk factors among participants in the Norwegian Breast Cancer Screening Program has been collected since 2006. We aimed to examine the validity of self-reported history of breast cancer and mammographic screening, as well as the reliability of weight and height amongt women attending the program.
METHODS: Information from a questionnaire handed in by participants in the program, 2006-2015, was linked to outcomes from the Cancer Registry of Norway. Sensitivity, specificity, and positive predictive values (PPV) were calculated for self-reported histories of breast cancer and screening. Results were stratified by five-year age groups and evaluated using the χ2 statistic. The reliability of self-reported weight and height were assessed using descriptive statistics, histograms, and mean differences.
RESULTS: A total of 538,907 of 611,711 (88%) women attending the program during the study period returned at least one part of the questionnaire. The overall sensitivity, specificity, and PPV for breast cancer and mammography were 96.5%, 99.8%, and 81.3%; and 99.9%, 84.4%, and 97.6% respectively. The mean difference in self-reported weight was 0.35 kg and for height was -0.14 cm, over a period of up to 10 years.
CONCLUSIONS: Norwegian women attending the screening program are reasonably accurate in self-reporting their breast cancer and mammography histories. On average, women consistently reported weight and height within one kg/cm.

Entities:  

Keywords:  Cancer screening; population characteristics; reliability and validity; sensitivity and specificity; surveys and questionnaires

Mesh:

Year:  2018        PMID: 29366395     DOI: 10.1177/1403494817749393

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  7 in total

1.  Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life.

Authors:  Marie Søfteland Sandvei; Lars J Vatten; Elisabeth Krefting Bjelland; Anne Eskild; Solveig Hofvind; Giske Ursin; Signe Opdahl
Journal:  Eur J Epidemiol       Date:  2018-08-06       Impact factor: 8.082

2.  The association of birthweight with age at natural menopause: a population study of women in Norway.

Authors:  Elisabeth K Bjelland; Jon M Gran; Solveig Hofvind; Anne Eskild
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

3.  Temporal trends in age at menarche and age at menopause: a population study of 312 656 women in Norway.

Authors:  M S Gottschalk; A Eskild; S Hofvind; J M Gran; E K Bjelland
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

4.  The relation of number of childbirths with age at natural menopause: a population study of 310 147 women in Norway.

Authors:  Marthe S Gottschalk; Anne Eskild; Solveig Hofvind; Elisabeth K Bjelland
Journal:  Hum Reprod       Date:  2022-01-28       Impact factor: 6.918

5.  Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.

Authors:  Sue Hudson; Kirsti Vik Hjerkind; Sarah Vinnicombe; Steve Allen; Cassia Trewin; Giske Ursin; Isabel Dos-Santos-Silva; Bianca L De Stavola
Journal:  Breast Cancer Res       Date:  2018-12-29       Impact factor: 6.466

6.  Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.

Authors:  Vilma Kriaucioniene; Janina Petkeviciene
Journal:  Int J Environ Res Public Health       Date:  2019-11-16       Impact factor: 3.390

7.  Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2018.

Authors:  Seri Hong; Yun Yeong Lee; Jaeho Lee; Yeol Kim; Kui Son Choi; Jae Kwan Jun; Mina Suh
Journal:  Cancer Res Treat       Date:  2020-10-20       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.